![](/img/cover-not-exists.png)
PCN134 RETROSPECTIVE CLAIMS ANALYSIS OF TREATMENT DURATION, HEALTHCARE RESOURCE UTILIZATION AND COSTS ASSOCIATED WITH FIRST-LINE TREATMENT OF NSCLC WITH AFATINIB VS. ERLOTINIB IN THE UNITED STATES
Samuelsen, C.H., Lim, J., Golembesky, A., Shrestha, S., Wang, L., Griebsch, I.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.258
Date:
May, 2019
File:
PDF, 382 KB
english, 2019